Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KetoNaph in Allergic Conjunctivitis
NCT00769886Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketotifen, naphazoline in allergic conjunctivitis (AC), sponsored by Bausch + Lomb. Started Oct 2008; status: completed.
02
Drugs
ketotifennaphazoline
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00769886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769886.